These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 9590692)

  • 1. Dramatic decreases in brain reward function during nicotine withdrawal.
    Epping-Jordan MP; Watkins SS; Koob GF; Markou A
    Nature; 1998 May; 393(6680):76-9. PubMed ID: 9590692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of repeated withdrawal episodes, nicotine dose, and duration of nicotine exposure on the severity and duration of nicotine withdrawal in rats.
    Skjei KL; Markou A
    Psychopharmacology (Berl); 2003 Jul; 168(3):280-92. PubMed ID: 12712232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicotine self-administration acutely activates brain reward systems and induces a long-lasting increase in reward sensitivity.
    Kenny PJ; Markou A
    Neuropsychopharmacology; 2006 Jun; 31(6):1203-11. PubMed ID: 16192981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of nicotinic acetylcholine or dopamine D1-like receptors in the central nucleus of the amygdala or the bed nucleus of the stria terminalis does not precipitate nicotine withdrawal in nicotine-dependent rats.
    Jonkman S; Markou A
    Neurosci Lett; 2006 May; 400(1-2):140-5. PubMed ID: 16563623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reward and somatic changes during precipitated nicotine withdrawal in rats: centrally and peripherally mediated effects.
    Watkins SS; Stinus L; Koob GF; Markou A
    J Pharmacol Exp Ther; 2000 Mar; 292(3):1053-64. PubMed ID: 10688623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonism of CRF receptors prevents the deficit in brain reward function associated with precipitated nicotine withdrawal in rats.
    Bruijnzeel AW; Zislis G; Wilson C; Gold MS
    Neuropsychopharmacology; 2007 Apr; 32(4):955-63. PubMed ID: 16943772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preadolescent tobacco smoke exposure leads to acute nicotine dependence but does not affect the rewarding effects of nicotine or nicotine withdrawal in adulthood in rats.
    Yamada H; Bishnoi M; Keijzers KF; van Tuijl IA; Small E; Shah HP; Bauzo RM; Kobeissy FH; Sabarinath SN; Derendorf H; Bruijnzeel AW
    Pharmacol Biochem Behav; 2010 Jun; 95(4):401-9. PubMed ID: 20211642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conditioned nicotine withdrawal profoundly decreases the activity of brain reward systems.
    Kenny PJ; Markou A
    J Neurosci; 2005 Jun; 25(26):6208-12. PubMed ID: 15987950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic treatment with the vasopressin 1b receptor antagonist SSR149415 prevents the dysphoria associated with nicotine withdrawal in rats.
    Qi X; Guzhva L; Ji Y; Bruijnzeel AW
    Behav Brain Res; 2015 Oct; 292():259-65. PubMed ID: 26112757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The nicotinic antagonist methyllycaconitine has differential effects on nicotine self-administration and nicotine withdrawal in the rat.
    Markou A; Paterson NE
    Nicotine Tob Res; 2001 Nov; 3(4):361-73. PubMed ID: 11694204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex differences in the reward deficit and somatic signs associated with precipitated nicotine withdrawal in rats.
    Tan S; Xue S; Behnood-Rod A; Chellian R; Wilson R; Knight P; Panunzio S; Lyons H; Febo M; Bruijnzeel AW
    Neuropharmacology; 2019 Dec; 160():107756. PubMed ID: 31487496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of prazosin, clonidine, and propranolol on the elevations in brain reward thresholds and somatic signs associated with nicotine withdrawal in rats.
    Bruijnzeel AW; Bishnoi M; van Tuijl IA; Keijzers KF; Yavarovich KR; Pasek TM; Ford J; Alexander JC; Yamada H
    Psychopharmacology (Berl); 2010 Dec; 212(4):485-99. PubMed ID: 20697697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adaptations in cholinergic transmission in the ventral tegmental area associated with the affective signs of nicotine withdrawal in rats.
    Bruijnzeel AW; Markou A
    Neuropharmacology; 2004 Sep; 47(4):572-9. PubMed ID: 15380374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Animal models of nicotine withdrawal: intracranial self-stimulation and somatic signs of withdrawal.
    Bauzo RM; Bruijnzeel AW
    Methods Mol Biol; 2012; 829():257-68. PubMed ID: 22231819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corticotropin-releasing factor-1 receptor activation mediates nicotine withdrawal-induced deficit in brain reward function and stress-induced relapse.
    Bruijnzeel AW; Prado M; Isaac S
    Biol Psychiatry; 2009 Jul; 66(2):110-7. PubMed ID: 19217073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Similar precipitated withdrawal effects on intracranial self-stimulation during chronic infusion of an e-cigarette liquid or nicotine alone.
    Harris AC; Muelken P; Smethells JR; Krueger M; LeSage MG
    Pharmacol Biochem Behav; 2017 Oct; 161():1-5. PubMed ID: 28867606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of withdrawal from intermittent and continuous nicotine exposure on reward deficit and somatic aspects of nicotine withdrawal and expression of α4β2* nAChRs in Wistar male rats.
    Semenova S; Jin X; McClure-Begley TD; Tadman MP; Marks MJ; Markou A
    Pharmacol Biochem Behav; 2018 Aug; 171():54-65. PubMed ID: 29908200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corticotropin-releasing factor within the central nucleus of the amygdala and the nucleus accumbens shell mediates the negative affective state of nicotine withdrawal in rats.
    Marcinkiewcz CA; Prado MM; Isaac SK; Marshall A; Rylkova D; Bruijnzeel AW
    Neuropsychopharmacology; 2009 Jun; 34(7):1743-52. PubMed ID: 19145226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic bupropion differentially alters the reinforcing, reward-enhancing and conditioned motivational properties of nicotine in rats.
    Paterson NE; Balfour DJ; Markou A
    Nicotine Tob Res; 2008 Jun; 10(6):995-1008. PubMed ID: 18584463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of NPY and the specific Y1 receptor agonist [D-His(26)]-NPY on the deficit in brain reward function and somatic signs associated with nicotine withdrawal in rats.
    Rylkova D; Boissoneault J; Isaac S; Prado M; Shah HP; Bruijnzeel AW
    Neuropeptides; 2008 Jun; 42(3):215-27. PubMed ID: 18468678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.